Structures of lung cancer-derived EGFR mutants and inhibitor complexes: Mechanism of activation and insights into differential inhibitor sensitivity

Documenti analoghi

• Oncogenic Transformation by Inhibitor-Sensitive and -Resistant EGFR Mutants
  di: Greulich, Heidi, et al.
  Pubblicazione: (2005)
• The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
  di: Yun, Cai-Hong, et al.
  Pubblicazione: (2008)
• Structural and Mechanistic Underpinnings of the Differential Drug Sensitivity of EGFR Mutations in Non-Small Cell Lung Cancer
  di: Eck, Michael J., et al.
  Pubblicazione: (2009)
• Novel mutant-selective EGFR kinase inhibitors against EGFR T790M
  di: Zhou, Wenjun, et al.
  Pubblicazione: (2009)
• Discovery and Optimization of Dibenzodiazepinones as Allosteric Mutant-Selective EGFR Inhibitors
  di: De Clercq, Dries J. H., et al.
  Pubblicazione: (2019)